Aristeia Capital’s Drugs Made In America Acquisition Corp. Rights DMAAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$107K Sell
887,834
-12,166
-1% -$1.46K ﹤0.01% 384
2025
Q1
$117K Buy
+900,000
New +$117K ﹤0.01% 333